Histopathological study of evening primrose oil effects on experimental diabetic neuropathy

Ultrastructural Pathology

Volumn 36, Issue 4, 2012, Pages 222-227

  Omran, Ola M ^a,b  

^a Assiut University   (Egypt)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Diabetic polyneuropathy; Evening primrose oil; Experimental study; Sciatic nerve; Streptozotocin

Indexed keywords

GAMMA LINOLENIC ACID; LINOLEIC ACID; PRIMROSE OIL; VEGETABLE OIL;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DIABETIC NEUROPATHY; DRUG EFFECT; ELECTRON MICROSCOPY; EVENING PRIMROSE; EXPERIMENTAL DIABETES MELLITUS; MALE; PATHOLOGY; RAT; SCIATIC NERVE; ULTRASTRUCTURE;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; GAMMA-LINOLENIC ACID; LINOLEIC ACIDS; MALE; MICROSCOPY, ELECTRON; OENOTHERA BIENNIS; PLANT OILS; RATS; SCIATIC NERVE;

ANIMALIA; OENOTHERA; RATTUS;

EID: 84864548542     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913123.2012.662268     Document Type: Article

References (40)

1. Kähler W, Kuklinski B, Rühlmann C. Diabetes mellitus-A free radical-Associated disease. Results of adjuvant antioxidant supplementation. Z Gesamte Inn Med 1993;48:223-232.
2. Stevens MJ, Feldman EL, Greene DA. Diabetic peripheral neuropathy. In: DeFronzo RA, ed. Current Management of Diabetes Mellitus. St. Louis: Mosby-Year Book;1998:160-165.
3. Cameron NE, Cotter MA. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 1997;46 Suppl 2:31-37.
4. Sri Balasubashini M, Rukkumani R, Menon VP. Protective effects of ferulic acid on hyperlipidemic diabetic rats. Acta Diabetol 2003;40:118-122.
5. Bhattacharya G. On the protection against alloxan diabetes by hexoses. Science 1954;120:841-843.
6. Schein PS, Cooney DA, McMenamin MG, Anderson T. Streptozotocin diabetes-further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver. Biochem Pharmacol. 1973;15:2625-2631.
7. Matkovics B, Kotorman M, Varga IS, Hai DQ, Varga C. Oxidative stress in experimental diabetes induced by streptozotocin. Acta Physiol Hung 1998;85:29-38.
8. Jakobsen J, Lundbaek K. Neuropathy in experimental diabetes: an animal model. Br Med J 1976;2:278-279.
9. Jakobsen J. Early and preventable changes of peripheral nerve structure and function in insulin-deficient diabetic rats. J Neurol Neurosurg Psychiatr 1979;42:509-518.
10. Sharma AK, Thomas PK, De Molina AF. Peripheral nerve fiber size in experimental diabetes. Diabetes 1977;26:689-692.
11. Sharma AK, Duguid IG, Blanchard DS, Thomas PK. The effect of insulin treatment on myelinated nerve fibre maturation and integrity and on body growth in streptozotocin-diabetic rats. J Neurol Sci 1985;67:285-297.
12. Wettasinghe M, Shahidi F, Amarowicz R. Identification and quantification of low molecular weight phenolic antioxidants in seeds of evening primrose (Oenothera biennis L.). J Agric Food Chem 2002;50:1267-1271.
13. Coffey T. The History and Folklore of North American Wildflowers. Boston: Houghton Mifflin;1993:356.
14. Zaitone SA, Moustafa YM, Mosaad SM, et al. Effect of evening primrose oil and omega-3 polyunsaturated Fatty acids on the cardiovascular risk of celecoxib in rats. J Cardiovasc Pharmacol 2011;58:72-79.
15. Carter JP. Gamma-linolenic acid as a nutrient. Food Tech 1988;42:72-82.
16. Thorpe SR, Baynes JW. Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging 1996;9: 69-77.
17. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-412.
18. Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M. C-Peptide Na+,K+-ATPase and diabetes. Exp Diabesity Res 2004;5:37-50.
19. Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 2003;52:2110-2120.
20. The St Thomas' Diabetic Study Group. Failure of improved glycaemic control to reverse diabetic autonomic neuropathy. Diabet Med 1986;3:330-334.
21. el Tahir KE, Ashour MM, al-Harbi MM. The respiratory effects of the volatile oil of the black seed (Nigella sativa) in guinea-pigs: elucidation of the mechanism(s) of action. Gen Pharmacol 1993;24:1115-1122.
22. Suresh Y, Das UN. Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: effect of omega-6 fatty acids. Nutrition 2003;19:93-114.
23. Su CG, Wen X, Bailey ST, et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 1999;104:383-389.
24. Fukuzawa M, Satoh J, Qiang X, et al. Inhibition of tumor necrosis factor-Alpha with anti-diabetic agents. Diabetes Res Clin Pract 1999;43:147-154.
25. Srivivasan A, Menon VP, Periaswamy V, Rajasekaran KN. Protection of pancreatic beta-cell by the potential antioxidant bis-o-hydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. J Pharm Pharm Sci 2003;6:327-333.
26. Nicholson JM, Arany EJ, Hill DJ. Changes in islet microvasculature following streptozotocin-induced beta-cell loss and subsequent replacement in the neonatal rat. Exp Biol Med (Maywood) 2010;235:189-198.
27. Pierson CR, Zhang W, Sima AA. Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration. J Neuropathol Exp Neurol 2003;62:765-779.
28. Chiarelli F, Santilli F, Mohn A. Role of growth factors in the development of diabetic complications. Horm Res 2000;53: 53-67.
29. Sakaue Y, Sanada M, Sasaki T, Kashiwagi A, Yasuda H. Amelioration of retarded neurite outgrowth of dorsal root ganglion neurons by overexpression of PKCdelta in diabetic rats. Neuroreport 2003;14:431-436.
30. Ryan CM, Geckle MO, Orchard TJ. Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro-And macrovascular complications. Diabetologia 2003;46:940-948.
31. Cermenati G, Abbiati F, Cermenati S, et al. Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation. J Lipid Res 2012;53:300-310.
32. Apfel SC. Nerve regeneration in diabetic neuropathy. Diabetes Obes Metab 1999;1:3-11.
33. Love A, Cotter MA, Cameron NE. Nerve function and regeneration in diabetic and galactosaemic rats: antioxidant and metal chelator effects. Eur J Pharmacol 1996;314:33-39.
34. Kim JM, Lee TH, Lee MC, et al. Endoneurial microangiopathy of sural nerve in experimental vacor-induced diabetes. Ultrastruct Pathol 2002;26:393-401.
35. Greenwood MD, Ressler MJ, Audette JL, et al. Significant retinal capillary basement membrane thickening in hyperglycemic and normoglycemic diabetic-prone (DP) BB Wistar rats. Ultrastruct Pathol 2011;35:97-105.
36. Gerbi A, Maixent JM, Ansaldi JL, et al. Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats. J Nutr 1999;129: 207-213.
37. Andriambeloson E, Baillet C, Vitte PA, Garotta G, Dreano M, Callizot N. Interleukin-6 attenuates the development of experimental diabetes-related neuropathy. Neuropathology 2006;26:32-42.
38. Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997;46 Suppl 2:S38-S42.
39. Murase K, Hattori A, Kohno M, Hayashi K. Stimulation of nerve growth factor synthesis/secretion in mouse astroglial cells by coenzymes. Biochem Mol Biol Int 1993;30:615-621.
40. Dimpfel W, Spüler M, Pierau FK, Ulrich H. Thioctic acid induces dose-dependent sprouting of neurites in cultured rat neuroblastoma cells. Dev Pharmacol Ther 1990;14:193-199.